Recent Articles
Why We Had to Add This Stock to Our 2020 “Screaming Buy” List
Our research and analysis have identified another name in biotech stocks with big potential in 2020.
Addressing Your Questions Heading Into the Roaring 2020s
One of my favorite things about starting a podcast in 2019 is that it allows me to connect with subscribers and listeners from all around the world. I love responding to your feedback, and from time to time I even like to reach out via Twitter (@MatthewMcCall) to ask for your questions and concerns about the market. During this busy holiday season, I decided it was time to reach back out to the Twitterverse. And you guys didn’t disappoint! You brought up some great topics for me to discuss. I received a lot of questions and concerns about the recent sell-off in cannabis stocks. So that’s where I focus my attention in this week’s MoneyLine podcast,
Best Stocks for 2020: Aimmune’s Allergy Solutions Position It for Huge Success
With Palforzia awaiting final FDA approval, 2020 could be a big year for Aimmune Therapeutics. AIMT could be one of the best stocks.
My Prediction Was Spot On Last Year… Could I Be Right Again?
It’s that time of year again… predictions time! Predictions are fun, but they are also important. As someone who invests in the hypergrowth trends of the future, I’m always looking ahead at what’s to come. In this week’s episode of MoneyLine, I first take a look back at the 10 predictions I laid out for 2019. I was correct on more than half of them – a pretty solid showing for 12 months of educated guesses. And a few more may still come to fruition before the New Year’s bell. One of my best 2019 predictions was related to the broad market’s performance. If I can brag a little bit… I nailed it. I said that the S&P 500 would be up 25% at some point during the year.
JPMorgan Data Shows the Consequences of Being a “Perma-Bear”
Ever since this bull market started, the financial media has been urging you to sell everything, go to cash, and start preparing for the end of the world. But with the economy still so strong – including the lowest unemployment in 50 years! – they’ve had to change their story. Now, Barron’s is speculating that stocks will be roughly flat next year. That’s right… as of Monday, Barron’s 2020 Outlook is for the S&P 500 to gain just 4%. That’s low enough to make some folks nervous about their retirement. But remember, you’ve got to take these things with a grain of salt. Fear sells, and the media need to attract eyeballs for their advertisers.
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.
